TrialVaccine2014

Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.

David Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.